Autotelic Bio
About:
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
Website: http://www.autotelic.co.kr
Top Investors: Korea Credit Guarantee Fund, Woori Bank, Aju IB Investment, UTC Investment Co., ST Pharm
Description:
Total Funding Amount:
22B KRW
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Cheongju, Ch'ungch'ong-bukto, South Korea
Founded Date:
2015-11-01
Contact Email:
BD(AT)autotelic.co.kr
Founders:
Number of Employees:
11-50
Last Funding Date:
2022-03-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai